Key developments: mRNA vaccines and therapeutics
European Pharmaceutical Review
FEBRUARY 14, 2023
A key benefit of mRNA therapeutics is that manufacturing time is fast compared to antibodies or protein-based drugs. The research also identified other challenges for mRNA therapeutics’ delivery , including their high cost, susceptibility to degradation by ribonucleases and limitations with drug delivery systems.
Let's personalize your content